Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Core Scientific Inc (CORZ) vs Moderna, Inc. (MRNA) Price & Performance

Core Scientific IncTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Core Scientific Inc vs Moderna, Inc. — how do they compare? Core Scientific Inc trades at $21.51 (market cap $6.35B), while Moderna, Inc. trades at $60.3 (market cap $24.18B). The key difference: Moderna, Inc. is far larger — about 3.8× Core Scientific Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Core Scientific Inc nearer its low. Which is the better fit depends on your goals.

CORZMRNA
Market Cap
$6.35B$24.18B
Sector
TechnologyHealth
52-Week High
$29.16$81.80
52-Week Low
$13.55$22.36
Enterprise Value
$8.88B$20.33B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Core Scientific Inc

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $59.81, up 1.08% today, with a bullish technical signal from moving averages and recent FDA approval for its mRNA flu vaccine mFLUSIVA. Despite beating Q2 2026 EPS estimates, revenue has declined from pandemic peaks, with a net income margin of -142.58% in 2026. The stock faces resistance near $61-$63, while support lies at $56-$59.

Outlook remains mixed; pipeline advancements in flu, Ebola, and oncology offer growth potential, but persistent losses and high valuation ratios pose risks. Analyst consensus is cautious with a $54.33 price target below current levels, reflecting concerns over profitability amid transitioning business focus.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Core Scientific Inc

Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.

Read more on CORZ

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA